Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

Direct-to-consumer drug sales aim to simplify pricing and increase transparency by allowing patients to buy directly from ...

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...

As health insurance costs soar, lowering prescription prices could help. But that will require reforms in Jefferson City and Topeka. Mike Burns is a pharmacist and a small-business owner. He also has ...

The not-for-profit cites everything from unpaid patient bills to its own staff’s health care costs as state regulators push to remedy “missing, incomplete and inaccurate” figures they say don’t add up ...

Q3 2025 Earnings Call Transcript October 29, 2025 Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.4798 EPS, expectations were $1.07. Operator: Greetings, and welcome ...

Amgen AMGN reported third-quarter 2025 adjusted earnings of $5.64 per share, which beat the Zacks Consensus Estimate of $5.00 ...

Health Affairs' Jeff Byers welcomes Allison Oakes, Chief Research Officer of Trilliant Health, to the pod to discuss ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...